Article info
Therapeutics/Prevention
Randomized clinical trial
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus
- Correspondence to : Dr Guillermo Umpierrez, Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, 49 Jesse Hill Jr. Dr. SE, Atlanta, GA 30308, USA; geumpie{at}emory.edu
Citation
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus
Publication history
- First published February 3, 2016.
Online issue publication
May 23, 2016
Article Versions
- Previous version (3 February 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/